Q1 2019
Released Aug 12, 2019, after the close
10-Q filed Aug 12, 2019, 43 days after period end · 0001213900-19-015337
Q1 2019 · 10-Q
Revenue—
Net Income-$20.06M-$20.06M N/M vs Q1 2018N/M vs Q4 2018
EPS Diluted-$0.52-$0.52 no prior Q1 2018 on fileno prior Q4 2018 on file
Operating Income-$92,342—
Operating Cash Flow-$8,332,000—
Free Cash Flowderived-$8,332,000—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2019 | Q1 2018 |
|---|---|---|
| Net Income | -$20.06M | -$4.37M |
| EPS Diluted | -$0.52 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immunovant, Inc. · CIK 1764013 · Engraved from SEC EDGAR